HS6ST2 was found to be a protective factor in bladder urothelial carcinoma and a risk factor in kidney renal papillary cell carcinoma, stomach adenocarcinoma, adrenocortical carcinoma, and according to Cox regression analyses (Fig. 4A). This evidence concerns the gene HS6ST2 and adrenal cortex carcinoma.